Target intelligence / Profile preview

Ankyrin repeat domain 18B pseudogene

Molecular classification: Pseudogene

Overview

Ankyrin repeat domain 18B pseudogene (ENSG00000259214) is a genomic sequence similar to the ankyrin repeat domain-containing genes but is classified as a *pseudogene*. Pseudogenes generally arise from duplication or retrotransposition events and accumulate mutations that prevent them from encoding functional proteins. While some pseudogenes may regulate the expression of their parent or related genes, there is no evidence indicating biological activity, disease linkage, or druggability for this entry. It is not considered a receptor, enzyme, ion channel, or transporter, and thus is not an actionable therapeutic target[4][2].

Beyond the preview

Go deeper on Ankyrin repeat domain 18B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 18B pseudogene.

Explore the full profile